GSK Applauds U.K.'s Tax Changes, Announces New Jobs And Manufacturing Facilities
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline is to invest £500 million in new U.K. manufacturing facilities in Ulverston, Montrose and Irvine, creating 1,000 jobs in the process.